Loss of syndecan-1 expression in most epithelial tumors such as cervical, lung, head and neck, squamous cell, and esophageal cancers is associated with tumor progression and reduced patient survival (98, 99, 100, 101), suggestive of a tumor suppressive role for syndecan-1. This evidence concerns the gene SDC1 and neoplasm.